Jared Senfeld
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jared Senfeld has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Ayanna Cobb
Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
1 shared publication- Chanmin Joung
Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
1 shared publication - Chao Li
Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
1 shared publication Christopher Mazzone
Eli Lilly Research Laboratories, Division of Eli Lilly and Company, Indianapolis, IN 46285, USA
1 shared publication- Da Young Oh
Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX, USA
1 shared publication - Jan-Bernd Funcke
Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, USA
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 23 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (4) , eady7993
Neuronal GPR75 deficiency protects against diet-induced obesity in a humanized mouse model
GPR75, a G protein–coupled receptor implicated in human obesity through loss-of-function variants, has emerged as a promising regulator of energy and metabolic homeostasis. To dissect its tissue-specific functions, we generated a humanized floxed Gpr75 mouse model with conditional deletions in the brain and adipose tissue. Mice with brain-specific Gpr75 deletion using Nestin-Cre were resistant to diet-induced obesity, primarily through suppressed food intake and modest increases in energy expenditure. In contrast, adipocyte-specific deletion of Gpr75 had minimal effects on systemic metabolism but modestly enhanced mitochondrial oxygen consumption in brown adipose tissue under cold exposure. Gpr75 expression was up-regulated in key brain regions and down-regulated in white adipose tissue under high-fat diet conditions, supporting a predominant central role in metabolic adaptation. Histological and transcriptomic analyses further revealed depot-specific effects on adipocyte morphology and hepatic lipid accumulation in global knockouts. These findings position GPR75 as a critical regulator of central energy balance and provide a mechanistic framework for developing brain-targeted therapies against obesity.
- 23 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (4) , eady7993
Top Cited PapersOpen AccessNeuronal GPR75 deficiency protects against diet-induced obesity in a humanized mouse model
GPR75, a G protein–coupled receptor implicated in human obesity through loss-of-function variants, has emerged as a promising regulator of energy and metabolic homeostasis. To dissect its tissue-specific functions, we generated a humanized floxed Gpr75 mouse model with conditional deletions in the brain and adipose tissue. Mice with brain-specific Gpr75 deletion using Nestin-Cre were resistant to diet-induced obesity, primarily through suppressed food intake and modest increases in energy expenditure. In contrast, adipocyte-specific deletion of Gpr75 had minimal effects on systemic metabolism but modestly enhanced mitochondrial oxygen consumption in brown adipose tissue under cold exposure. Gpr75 expression was up-regulated in key brain regions and down-regulated in white adipose tissue under high-fat diet conditions, supporting a predominant central role in metabolic adaptation. Histological and transcriptomic analyses further revealed depot-specific effects on adipocyte morphology and hepatic lipid accumulation in global knockouts. These findings position GPR75 as a critical regulator of central energy balance and provide a mechanistic framework for developing brain-targeted therapies against obesity.